桂林三金药业股份有限公司关于为孙公司提供担保的进展公告

Summary of Key Points Core Viewpoint - The company has provided a guarantee for its wholly-owned subsidiary, Bai Fan Biotechnology (Shanghai) Co., Ltd., amounting to RMB 20 million, which is part of a larger approved guarantee limit of up to RMB 270 million for the fiscal year 2025 [2][4]. Group 1: Guarantee Overview - The company has agreed to provide a joint liability guarantee for Bai Fan Biotechnology's credit line of RMB 20 million with Xiamen International Bank Shanghai Branch, effective from January 23, 2026, to April 23, 2028 [3]. - The total actual guarantee balance for the company and its subsidiaries is RMB 26.371 million, representing 8.76% of the company's most recent audited net assets [2][6]. Group 2: Guarantee Approval Process - The guarantee limit was approved during the company's board meeting on April 24, 2025, and at the annual shareholders' meeting on May 16, 2025, allowing for a total guarantee amount of up to RMB 270 million for its subsidiaries [4]. - The remaining available guarantee limit for Bai Fan Biotechnology after this transaction is RMB 13 million [4]. Group 3: Guarantee Agreement Details - The guarantee covers all principal debts, interest, penalties, and associated costs related to the RMB 20 million loan [5]. - The guarantee period extends for three years from the date of contract effectiveness, with potential extensions based on agreement [6].